| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/17/1997 | WO1997025042A1 Use of an agonist of ppar-alpha and ppar-gamma for the treatment of syndrom x |
| 07/17/1997 | WO1997025041A1 Benzimidzolyl neuropeptide y receptor antagonists |
| 07/17/1997 | WO1997025040A1 Substituted benzopyrans |
| 07/17/1997 | WO1997025039A1 Use of carbonic anhydrase inhibitors (cah) to prepare a drug for cancer therapy |
| 07/17/1997 | WO1997025038A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of benign prostatic hypertrophy |
| 07/17/1997 | WO1997025037A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma |
| 07/17/1997 | WO1997025036A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes |
| 07/17/1997 | WO1997025035A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms |
| 07/17/1997 | WO1997025034A1 Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer |
| 07/17/1997 | WO1997025033A1 Antithrombotic diamines |
| 07/17/1997 | WO1997025032A2 Monoglyceride compositions and their use against helicobacter |
| 07/17/1997 | WO1997025031A1 Methods of using integrin modulators |
| 07/17/1997 | WO1997025030A1 Multiple unit effervescent dosage forms comprising protonpump inhibitor |
| 07/17/1997 | WO1997025028A1 Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads |
| 07/17/1997 | WO1997025025A1 Combination injection preparation |
| 07/17/1997 | WO1997025020A1 Cosmetic and dermatological sunscreen formulations containing triazine derivatives and alkane carboxylic acids |
| 07/17/1997 | WO1997024929A1 Human g-protein coupled receptor |
| 07/17/1997 | WO1997024924A1 The preservation of tissue during removal, storage and implantation |
| 07/17/1997 | WO1997017937A3 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders |
| 07/17/1997 | WO1997012969A3 Fmr1-related protein |
| 07/17/1997 | WO1997012042A3 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 07/17/1997 | WO1997009429A3 Compounds and methods for diagnosis of tuberculosis |
| 07/17/1997 | WO1997009428A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/17/1997 | DE3590054C1 Compositions for herpes virus infections treatment |
| 07/17/1997 | DE19601403A1 Use of 1-(5-hydroxy-5-methyl)-hexyl-3-methyl-7-propyl-xanthine |
| 07/17/1997 | DE19601303A1 Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln Novel benzoylguanidine derivatives, processes for their preparation and their use in the preparation of medicaments |
| 07/17/1997 | DE19601263A1 Anthelmintische Paste Anthelmintic paste |
| 07/17/1997 | DE19601104A1 Kosmetische und dermatologische Lichtschutzzubereitungen mit einem Gehalt an Triazinderivaten und Alkancarbonsäuren Cosmetic and dermatological light protection preparations containing triazine derivatives and alkane carboxylic acids |
| 07/17/1997 | DE19600934A1 Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung Substituted aza and Diazacycloheptan- and Cyclooctanverbindungen and their use |
| 07/17/1997 | DE19600721A1 Verwendung von Inhibitoren des Carboanhydratase (CAH) zum Herstellen eines Medikaments zur Behandlung von Krebs Use of inhibitors of carbonic anhydrase (CAH) for preparing a medicament for treating cancer |
| 07/17/1997 | CA2242778A1 Process for isolating igg and iga |
| 07/17/1997 | CA2242632A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrome x |
| 07/17/1997 | CA2242609A1 Heterocycle-condensed morphinoid derivatives (ii) |
| 07/17/1997 | CA2242589A1 Composition containing diosgenin |
| 07/17/1997 | CA2242579A1 Benzimidzolyl neuropeptide y receptor antagonists |
| 07/17/1997 | CA2242514A1 Immunoconjugate for the treatment of aids |
| 07/17/1997 | CA2242430A1 Calcium binding proteolipid compositions and methods |
| 07/17/1997 | CA2242411A1 Disinfecting compositions and processes for disinfecting surfaces |
| 07/17/1997 | CA2242391A1 Disinfecting compositions and processes for disinfecting surfaces |
| 07/17/1997 | CA2242385A1 Antithrombotic agents and methods of use |
| 07/17/1997 | CA2242364A1 Combination injection preparation |
| 07/17/1997 | CA2242327A1 Novel substituted imidazole compounds |
| 07/17/1997 | CA2241993A1 Therapeutic compounds |
| 07/17/1997 | CA2241893A1 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity |
| 07/17/1997 | CA2241870A1 Macrocyclic compounds made from suboxide units |
| 07/17/1997 | CA2241830A1 Polymers |
| 07/17/1997 | CA2241623A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms |
| 07/17/1997 | CA2241564A1 Wsx receptor and ligands |
| 07/17/1997 | CA2241559A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma |
| 07/17/1997 | CA2241556A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes |
| 07/17/1997 | CA2241519A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of benign prostatic hypertrophy |
| 07/17/1997 | CA2241462A1 Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer |
| 07/17/1997 | CA2241169A1 Inhibitors of madcam-1-mediated interactions and methods of use therefor |
| 07/17/1997 | CA2240685A1 Aqueous prolonged release formulation |
| 07/17/1997 | CA2240467A1 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| 07/17/1997 | CA2239254A1 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives, preparation thereof, intermediates thereof and drugs containing same |
| 07/17/1997 | CA2236007A1 Antithrombotic diamines |
| 07/17/1997 | CA2195157A1 (1h-indol-4-yl)-piperidine or tetrahydropyridine ethylamines and ethylcarboxamides |
| 07/17/1997 | CA2194945A1 2-oxo- and 2-thio-1,2- dihydroquinolinyl-oxazolidinones |
| 07/17/1997 | CA2194938A1 Pyrido-fused thienyl- and furanyl-oxazolidinones |
| 07/16/1997 | EP0784058A1 Derivatives of aspartic acid, preparation and use thereof |
| 07/16/1997 | EP0784054A1 1,2,3,4-tetrahydroquinoxalinedione derivative |
| 07/16/1997 | EP0783890A1 Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine for the treatment of fungal dermatitis |
| 07/16/1997 | EP0783889A1 Pharmaceutical granulates containing an intragranular disintegrant |
| 07/16/1997 | EP0783888A1 Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis |
| 07/16/1997 | EP0783887A2 Topical compositions for the treatment of hyperproliferative skin disease |
| 07/16/1997 | EP0783886A2 Use of taxol for the manufacture of a medicament for the treatment of cancer |
| 07/16/1997 | EP0783885A2 Use of taxol for the manufacture of a medicament for the treatment of cancer |
| 07/16/1997 | EP0783884A1 Preventive and remedy for diarrhea |
| 07/16/1997 | EP0783528A1 Method of producing starch decomposition products |
| 07/16/1997 | EP0783518A1 Inhibitors of farnesyl-protein transferase |
| 07/16/1997 | EP0783517A2 Thiol-free inhibitors of farnesyl-protein transferase |
| 07/16/1997 | EP0783514A1 Sterol compositions from pulping soap |
| 07/16/1997 | EP0783512A1 Novel androstanes for inducing hypothalamic effects |
| 07/16/1997 | EP0783509A1 Human transcription factor iia |
| 07/16/1997 | EP0783508A1 The oligosaccharide structure of a ligand for e and p selectin |
| 07/16/1997 | EP0783507A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 07/16/1997 | EP0783506A1 New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use |
| 07/16/1997 | EP0783505A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 07/16/1997 | EP0783504A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE |
| 07/16/1997 | EP0783503A1 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO 1,2-a]PYRAZINE DERIVATIVES |
| 07/16/1997 | EP0783502A1 New carboxamides with antifungal activity |
| 07/16/1997 | EP0783501A1 New pyrimidone derivatives with antifungal activity |
| 07/16/1997 | EP0783500A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 07/16/1997 | EP0783499A1 Benzofuran derivatives as tachykinin antagonists |
| 07/16/1997 | EP0783498A1 Substituted aryl piperazines as neurokinin antagonists |
| 07/16/1997 | EP0783495A1 Quinoxaline derivatives useful in therapy |
| 07/16/1997 | EP0783494A1 Certain aminomethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
| 07/16/1997 | EP0783490A1 1-acyl-4-aliphatylaminopiperidine compounds |
| 07/16/1997 | EP0783488A1 Five membered heterocyclic compounds |
| 07/16/1997 | EP0783486A1 Novel prostaglandin synthase inhibitors |
| 07/16/1997 | EP0783474A1 Compounds for the suppression of hiv tat transactivation |
| 07/16/1997 | EP0783398A1 Razor cartridges comprising wound healing compositions |
| 07/16/1997 | EP0783326A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 07/16/1997 | EP0783320A1 Protection of hemopoietic cells during chemotherapy or radiotherapy |
| 07/16/1997 | EP0783317A1 Mimetics of senescent cell derived inhibitors of dna synthesis |
| 07/16/1997 | EP0783314A2 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
| 07/16/1997 | EP0783311A1 Synthetic ganglioside derivatives |
| 07/16/1997 | EP0783310A1 Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies |
| 07/16/1997 | EP0783309A2 Use of a corticosteroid to reduce the adverse effects of a perfluorochemical emulsion |